Diagnostic Lab Testing Transparency Act

The Diagnostic Lab Testing Transparency Act, also known as Bill 118 hr 3248, is a piece of legislation currently being considered by the US Congress. The main goal of this bill is to increase transparency and accountability in the diagnostic lab testing industry.

One of the key provisions of the bill is the requirement for diagnostic lab testing facilities to disclose the prices of their services to patients before they undergo any testing. This is aimed at helping patients make more informed decisions about their healthcare and avoid surprise billing.

Additionally, the bill includes measures to prevent overcharging by diagnostic lab testing facilities. It requires these facilities to provide itemized bills to patients, detailing the cost of each test and service provided. This will help ensure that patients are not being charged excessively for their diagnostic testing. Furthermore, the Diagnostic Lab Testing Transparency Act includes provisions to improve the quality of diagnostic lab testing services. It requires facilities to adhere to certain quality standards and guidelines set forth by the Department of Health and Human Services. This will help ensure that patients receive accurate and reliable test results. Overall, the Diagnostic Lab Testing Transparency Act aims to promote transparency, accountability, and quality in the diagnostic lab testing industry. By requiring facilities to disclose prices, prevent overcharging, and adhere to quality standards, this bill seeks to protect patients and improve the overall healthcare system.